30 results on '"Montera MW"'
Search Results
2. Diretrizes brasileiras de antiagregantes plaquetários e anticoagulantes em cardiologia
- Author
-
Valdir Ambrósio Moisés, Fernando Bacal, Montenegro Ce, Montera Mw, Castro I, Jose C. Nicolau, Lorga Filho Am, Montenegro St, Portal Vl, Macq Lopes, Ramos Ai, Carisi Anne Polanczyk, Tsv Jardim, Faria Neto, Ferreira Ac, Simão Af, F Darrieux, Elbio Antonio D'Amico, Leopoldo S. Piegas, Silva Ee, Fenelon G, Sociedade Brasileira de Cardiologia, Flávio Tarasoutchi, Gagliardi Rj, Leite Re, Moraes Neto Fr, Dikran Armaganijan, Heinisch Rh, Esporcatte R, Mvb Malachias, Flávio de Souza Brito, Timerman A, PC Yu, Iran Gonçalves, Correa Filho H, Danielle Menosi Gualandro, Melo Cc, Luciano Moreira Baracioli, Greco Ai, Pinho C, AD Azmus, Antonio Eduardo Pesaro, A Franci, Evaristo Ef, Gomes Fl, Leandro Ioschpe Zimerman, Andrade, Renato A. K. Kalil, Franco Ra, Scudeler Tl, Clausell No, Gaz Mv, Marques Ac, Renato D. Lopes, Luiz Alberto Mattos, Pedro Beraldo de Andrade, Acs Sousa, Joyce M. Annichino-Bizzacchi, de Paola Aa, Alexandre Schaan de Quadros, Fábio Fernandes, Pires Lj, Caramelli B, Machado Neto Ea, Calderaro D, Alves Rc, Atié J, Magalhães Lp, Accorsi Ta, Carlos V. Serrano, Lavítola Pl, D A R Moreira, Ganem F, João Fernando Monteiro Ferreira, Barbosa Mr, Soeiro Am, Edison F. Paiva, Bocchi Ea, Pedro Silvio Farsky, Lemos Neto Pa, GR Morais, Gilson Soares Feitosa, Lopes As, Bacellar Ms, Rrcv Giraldez, LB Silva, R. F. Ramos, Márcio Jansen de Oliveira Figueiredo, Souza Neto Jd, L. A. F. Lisboa, Manica Al, Oscar Pereira Dutra, FR Mattos, A Volschan, Kalil Filho R, Alvaro Avezum, Otávio Rizzi Coelho, Cjdg Barbosa, BA Mendes, Edson Stefanini, and Alves Br
- Subjects
medicine.medical_specialty ,lcsh:Diseases of the circulatory (Cardiovascular) system ,Platelet Antiaggregants ,business.industry ,lcsh:RC666-701 ,Internal medicine ,Cardiology ,medicine ,Cardiology and Cardiovascular Medicine ,business - Published
- 2013
3. ATUALIZAÇÃO DAS DIRETRIZES BRASILEIRAS DE VALVOPATIAS: ABORDAGEM DAS LESÕES ANATOMICAMENTE IMPORTANTES
- Author
-
Tarasoutchi, F, primary, Montera, MW, additional, Ramos, AIO, additional, Sampaio, RO, additional, Rosa, VEE, additional, Accorsi, TAD, additional, Lopes, ASSA, additional, Fernandes, JRC, additional, Pires, LJT, additional, Spina, GS, additional, Vieira, MLC, additional, Lavitola, PL, additional, Bignoto, TC, additional, Togna, DJD, additional, Mesquita, ET, additional, Esteves, WAM, additional, Atik, FA, additional, Colafranceschi, AS, additional, Moisés, VA, additional, Kiyose, AT, additional, Pomerantzeff, PMA, additional, Lemos, PA, additional, Brito Jr., FS, additional, Clara, Weksler, additional, Brandão, CMA, additional, Poffo, R, additional, Simões, R, additional, Rassi, S, additional, Leães, PE, additional, Mourilhe-Rocha, R, additional, Pena, JLB, additional, Jatene, FB, additional, Barbosa, MM, additional, Souza Neto, JD, additional, and Saraiva, JFK, additional
- Published
- 2017
- Full Text
- View/download PDF
4. Diretriz de assistência circulatória mecânica da sociedade brasileira de cardiologia
- Author
-
Ayub-Ferreira, SM, primary, Souza Neto, JD, additional, Almeida, DR, additional, Biselli, B, additional, Avila, MS, additional, Colafranceschi, AS, additional, Stefanello, B, additional, Carvalho, BM, additional, Polanczyk, CA, additional, Galantini, DR, additional, Bocchi, EA, additional, Chamlian, EG, additional, Hojaij, EM, additional, Gaiotto, FA, additional, Pinton, FA, additional, Jatene, FB, additional, Ramires, FJA, additional, Atik, FA, additional, Figueira, F, additional, Bacal, F, additional, Galas, FRBG, additional, Brito, FS, additional, Conceição-Souza, GE, additional, Ribeiro, GCA, additional, Pinheiro Jr., JA, additional, Souza, JM, additional, Rossi Neto, JM, additional, Lima, JLC, additional, Mejía, JC, additional, Fernandes, JR, additional, Baumworcel, L, additional, Moura, LAZ, additional, Hajjar, LA, additional, Beck-da-Silva, L, additional, Rohde, LEP, additional, Seguro, LFBC, additional, Pinheiro, ML, additional, Park, M, additional, Fernandes, MR, additional, Montera, MW, additional, Alves, MSL, additional, Wanderley Jr., MRB, additional, Hossne, N, additional, Fernandes, PMP, additional, Lemos, P, additional, Schneidewind, RO, additional, Uchoa, RB, additional, Honorato, R, additional, Mangini, S, additional, Falcão, SNRS, additional, Lopes, SAV, additional, Strabelli, TMV, additional, Guimarães, TCF, additional, Campanili, TCGF, additional, and Issa, VS, additional
- Published
- 2016
- Full Text
- View/download PDF
5. Diretriz Brasileira de Valvopatias - SBC 2011/ I Diretriz Interamericana de Valvopatias - SIAC 2011
- Author
-
Tarasoutchi, F, primary, Montera, MW, additional, Grinberg, M, additional, Barbosa, MR, additional, Piñeiro, DJ, additional, Sánchez, CRM, additional, and Barbosa, MM, additional
- Published
- 2011
- Full Text
- View/download PDF
6. Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024.
- Author
-
Fernandes F, Simões MV, Correia EB, Marcondes-Braga FG, Coelho-Filho OR, Mesquita CT, Mathias Junior W, Antunes MO, Arteaga-Fernández E, Rochitte CE, Ramires FJA, Alves SMM, Montera MW, Lopes RD, Oliveira Junior MT, Scolari FL, Avila WS, Canesin MF, Bocchi EA, Bacal F, Moura LZ, Saad EB, Scanavacca MI, Valdigem BP, Cano MN, Abizaid AAC, Ribeiro HB, Lemos Neto PA, Ribeiro GCA, Jatene FB, Dias RR, Beck-da-Silva L, Rohde LEP, Bittencourt MI, Pereira ADC, Krieger JE, Villacorta Junior H, Martins WA, Figueiredo Neto JA, Cardoso JN, Pastore CA, Jatene IB, Tanaka ACS, Hotta VT, Romano MMD, Albuquerque DC, Mourilhe-Rocha R, Hajjar LA, Brito Junior FS, Caramelli B, Calderaro D, Farsky PS, Colafranceschi AS, Pinto IMF, Vieira MLC, Danzmann LC, Barberato SH, Mady C, Martinelli Filho M, Torbey AFM, Schwartzmann PV, Macedo AVS, Ferreira SMA, Schmidt A, Melo MDT, Lima Filho MO, Sposito AC, Brito FS, Biolo A, Madrini Junior V, Rizk SI, and Mesquita ET
- Subjects
- Humans, Cardiomyopathy, Hypertrophic therapy, Cardiomyopathy, Hypertrophic diagnosis
- Published
- 2024
- Full Text
- View/download PDF
7. Brazilian Society of Cardiology Guideline on Myocarditis - 2022.
- Author
-
Montera MW, Marcondes-Braga FG, Simões MV, Moura LAZ, Fernandes F, Mangine S, Oliveira Júnior AC, Souza ALAAG, Ianni BM, Rochitte CE, Mesquita CT, de Azevedo Filho CF, Freitas DCA, Melo DTP, Bocchi EA, Horowitz ESK, Mesquita ET, Oliveira GH, Villacorta H, Rossi Neto JM, Barbosa JMB, Figueiredo Neto JA, Luiz LF, Hajjar LA, Beck-da-Silva L, Campos LAA, Danzmann LC, Bittencourt MI, Garcia MI, Avila MS, Clausell NO, Oliveira NA Jr, Silvestre OM, Souza OF, Mourilhe-Rocha R, Kalil Filho R, Al-Kindi SG, Rassi S, Alves SMM, Ferreira SMA, Rizk SI, Mattos TAC, Barzilai V, Martins WA, and Schultheiss HP
- Subjects
- Brazil, Humans, Societies, Medical, Cardiology, Cardiovascular System, Myocarditis diagnosis, Myocarditis therapy
- Published
- 2022
- Full Text
- View/download PDF
8. Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021.
- Author
-
Simões MV, Fernandes F, Marcondes-Braga FG, Scheinberg P, Correia EB, Rohde LEP, Bacal F, Alves SMM, Mangini S, Biolo A, Beck-da-Silva L, Szor RS, Marques Junior W, Oliveira ASB, Cruz MW, Bueno BVK, Hajjar LA, Issa AFC, Ramires FJA, Coelho Filho OR, Schmidt A, Pinto IMF, Rochitte CE, Vieira MLC, Mesquita CT, Ramos CD, Soares-Junior J, Romano MMD, Mathias Junior W, Garcia Junior MI, Montera MW, Melo MDT, Silva SME, Garibaldi PMM, Alencar Neto AC, Lopes RD, Ávila DX, Viana D, Saraiva JFK, Canesin MF, Oliveira GMM, and Mesquita ET
- Subjects
- Humans, Amyloidosis diagnosis, Amyloidosis therapy, Cardiomyopathies diagnostic imaging, Cardiomyopathies therapy
- Published
- 2021
- Full Text
- View/download PDF
9. Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021.
- Author
-
Marcondes-Braga FG, Moura LAZ, Issa VS, Vieira JL, Rohde LE, Simões MV, Fernandes-Silva MM, Rassi S, Alves SMM, Albuquerque DC, Almeida DR, Bocchi EA, Ramires FJA, Bacal F, Rossi Neto JM, Danzmann LC, Montera MW, Oliveira Junior MT, Clausell N, Silvestre OM, Bestetti RB, Bernadez-Pereira S, Freitas AF Jr, Biolo A, Barretto ACP, Jorge AJL, Biselli B, Montenegro CEL, Santos Júnior EGD, Figueiredo EL, Fernandes F, Silveira FS, Atik FA, Brito FS, Souza GEC, Ribeiro GCA, Villacorta H, Souza Neto JD, Goldraich LA, Beck-da-Silva L, Canesin MF, Bittencourt MI, Bonatto MG, Moreira MDCV, Avila MS, Coelho Filho OR, Schwartzmann PV, Mourilhe-Rocha R, Mangini S, Ferreira SMA, Figueiredo Neto JA, and Mesquita ET
- Subjects
- American Heart Association, Brazil, Humans, Heart Failure
- Published
- 2021
- Full Text
- View/download PDF
10. Emerging Topics in Heart Failure: COVID-19 and Heart Failure.
- Author
-
Goldraich LA, Silvestre OM, Gomes E, Biselli B, and Montera MW
- Subjects
- Humans, Pandemics, SARS-CoV-2, COVID-19, Heart Failure epidemiology
- Published
- 2020
- Full Text
- View/download PDF
11. Brazilian Cardio-oncology Guideline - 2020.
- Author
-
Hajjar LA, Costa IBSDSD, Lopes MACQ, Hoff PMG, Diz MDPE, Fonseca SMR, Bittar CS, Rehder MHHDS, Rizk SI, Almeida DR, Fernandes GDS, Beck-da-Silva L, Campos CAHM, Montera MW, Alves SMM, Fukushima JT, Santos MVCD, Negrão CE, Silva TLFD, Ferreira SMA, Malachias MVB, Moreira MDCV, Valente Neto MMR, Fonseca VCQ, Soeiro MCFA, Alves JBS, Silva CMPDC, Sbano J, Pavanello R, Pinto IMF, Simão AF, Dracoulakis MDA, Hoff AO, Assunção BMBL, Novis Y, Testa L, Alencar Filho AC, Cruz CBBV, Pereira J, Garcia DR, Nomura CH, Rochitte CE, Macedo AVS, Marcatti PTF, Mathias Junior W, Wiermann EG, Val RD, Freitas H, Coutinho A, Mathias CMC, Vieira FMAC, Sasse AD, Rocha V, Ramires JAF, and Kalil Filho R
- Subjects
- Brazil, Humans, Medical Oncology, Neoplasms therapy
- Published
- 2020
- Full Text
- View/download PDF
12. Update of the Brazilian Guidelines for Valvular Heart Disease - 2020.
- Author
-
Tarasoutchi F, Montera MW, Ramos AIO, Sampaio RO, Rosa VEE, Accorsi TAD, Santis A, Fernandes JRC, Pires LJT, Spina GS, Vieira MLC, Lavitola PL, Ávila WS, Paixão MR, Bignoto T, Togna DJD, Mesquita ET, Esteves WAM, Atik F, Colafranceschi AS, Moises VA, Kiyose AT, Pomerantzeff PMA, Lemos PA, Brito Junior FS, Weksler C, Brandão CMA, Poffo R, Simões R, Rassi S, Leães PE, Mourilhe-Rocha R, Pena JLB, Jatene FB, Barbosa MM, Abizaid A, Ribeiro HB, Bacal F, Rochitte CE, Fonseca JHAPD, Ghorayeb SKN, Lopes MACQ, Spina SV, Pignatelli RH, and Saraiva JFK
- Subjects
- American Heart Association, Brazil, Humans, Heart Valve Diseases diagnosis
- Published
- 2020
- Full Text
- View/download PDF
13. Takotsubo Syndrome: A Recurrent Disease?
- Author
-
Fernandes F and Montera MW
- Subjects
- Chronic Disease, Electrocardiography, Humans, Recurrence, Takotsubo Cardiomyopathy
- Published
- 2020
- Full Text
- View/download PDF
14. Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda.
- Author
-
Rohde LEP, Montera MW, Bocchi EA, Clausell NO, Albuquerque DC, Rassi S, Colafranceschi AS, Freitas AF Junior, Ferraz AS, Biolo A, Barretto ACP, Ribeiro ALP, Polanczyk CA, Gualandro DM, Almeida DR, Silva ERR, Figueiredo EL, Mesquita ET, Marcondes-Braga FG, Cruz FDD, Ramires FJA, Atik FA, Bacal F, Souza GEC, Almeida GLG Junior, Ribeiro GCA, Villacorta H Junior, Vieira JL, Souza JD Neto, Rossi JM Neto, Figueiredo JA Neto, Moura LAZ, Goldraich LA, Beck-da-Silva L, Danzmann LC, Canesin MF, Bittencourt MI, Garcia MI, Bonatto MG, Simões MV, Moreira MCV, Silva MMF, Olivera MT Junior, Silvestre OM, Schwartzmann PV, Bestetti RB, Rocha RM, Simões R, Pereira SB, Mangini S, Alves SMM, Ferreira SMA, Issa VS, Barzilai VS, and Martins WA
- Subjects
- Acute Disease, Brazil, Chronic Disease, Heart Failure mortality, Humans, Risk Factors, Heart Failure diagnosis, Heart Failure therapy
- Published
- 2018
- Full Text
- View/download PDF
15. [Not Available].
- Author
-
Ayub-Ferreira SM, Souza JD Neto, Almeida DR, Biselli B, Avila MS, Colafranceschi AS, Stefanello B, Carvalho BM, Polanczyk CA, Galantini DR, Bocchi EA, Chamlian EG, Hojaij EM, Gaiotto FA, Pinton FA, Jatene FB, Ramires F, Atik FA, Figueira F, Bacal F, Galas F, Brito FS, Conceição-Souza GE, Ribeiro G, Ja P Jr, Souza JM, Rossi JM Neto, Lima J, Mejía JC, Fernandes JR, Baumworcel L, Moura L, Hajjar LA, Beck-da-Silva L, Rohde L, Seguro L, Pinheiro ML, Park M, Fernandes MR, Montera MW, Alves M, Mrb W Jr, Hossne N, Fernandes P, Lemos P, Schneidewind RO, Uchoa RB, Honorato R, Mangini S, Falcão S, Lopes S, Strabelli T, Guimarães T, Campanili T, and Issa VS
- Subjects
- Assisted Circulation methods, Brazil, Extracorporeal Membrane Oxygenation methods, Heart Failure therapy, Humans, Risk Factors, Societies, Medical, Assisted Circulation instrumentation, Assisted Circulation standards, Extracorporeal Membrane Oxygenation instrumentation, Extracorporeal Membrane Oxygenation standards, Heart-Assist Devices
- Published
- 2016
- Full Text
- View/download PDF
16. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.
- Author
-
Beck-da-Silva L, Piardi D, Soder S, Rohde LE, Pereira-Barretto AC, de Albuquerque D, Bocchi E, Vilas-Boas F, Moura LZ, Montera MW, Rassi S, and Clausell N
- Subjects
- Aged, Anemia, Iron-Deficiency epidemiology, Double-Blind Method, Female, Ferric Oxide, Saccharated, Heart Failure epidemiology, Humans, Infusions, Intravenous, Male, Middle Aged, Prospective Studies, Treatment Outcome, Anemia, Iron-Deficiency blood, Anemia, Iron-Deficiency drug therapy, Ferric Compounds administration & dosage, Ferrous Compounds administration & dosage, Glucaric Acid administration & dosage, Heart Failure blood, Heart Failure drug therapy
- Abstract
Background: Anemia in heart failure patients and has been associated with increased morbi-mortality. Previous studies have treated anemia in heart failure patients with either erythropoietin alone or combination of erythropoietin and intravenous (i.v.) iron. However, the effect of i.v. or oral (p.o.) iron supplementation alone in heart failure patients with anemia was virtually unknown., Aim: To compare, in a double-blind design, the effects of i.v. iron versus p.o. iron in anemic heart failure patients., Methods: IRON-HF study was a multicenter, investigator initiated, randomized, double-blind, placebo controlled trial that enrolled anemic heart failure patients with preserved renal function, low transferrin saturation (TSat) and low-to-moderately elevated ferritin levels. Interventions were Iron Sucrose i.v. 200 mg, once a week, for 5 weeks, ferrous sulfate 200 mg p.o. TID, for 8 weeks, or placebo. Primary endpoint was variation of peak oxygen consumption (peak VO2) assessed by ergospirometry over 3 month follow-up., Results: Eighteen patients had full follow-up data. There was an increment of 3.5 ml/kg/min in peak VO2 in the i.v. iron group. There was no increment in peak VO2 in the p.o. iron group. Patients' ferritin and TSat increased significantly in both treated groups. Hemoglobin increased similarly in all groups., Conclusion: I.v. iron seems to be superior in improving functional capacity of heart failure patients. However, correction of anemia seems to be at least similar between p.o. iron and i.v. iron supplementation., (Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
17. [Brazilian guidelines on platelet antiaggregants and anticoagulants in cardiology].
- Author
-
Lorga Filho AM, Azmus AD, Soeiro AM, Quadros AS, Avezum A Jr, Marques AC, Franci A, Manica AL, Volschan A, De Paola AA, Greco AI, Ferreira AC, Sousa AC, Pesaro AE, Simão AF, Lopes AS, Timerman A, Ramos AI, Alves BR, Caramelli B, Mendes BA, Polanczyk CA, Montenegro CE, Barbosa CJ, Serrano CV Jr, Melo CC, Pinho C, Moreira DA, Calderaro D, Gualandro DM, Armaganijan D, Machado Neto EA, Bocchi EA, Paiva EF, Stefanini E, D'Amico E, Evaristo EF, Silva EE, Fernandes F, Brito FS Jr, Bacal F, Ganem F, Gomes FL, Mattos FR, Moraes Neto FR, Tarasoutchi F, Darrieux FC, Feitosa GS, Fenelon G, Morais GR, Correa Filho H, Castro I, Gonçalves I Jr, Atié J, Souza Neto JD, Ferreira JF, Nicolau JC, Faria Neto JR, Annichino-Bizzacchi JM, Zimerman LI, Piegas LS, Pires LJ, Baracioli LM, Silva LB, Mattos LA, Lisboa LA, Magalhães LP, Lopes MA, Montera MW, Figueiredo MJ, Malachias MV, Gaz MV, Andrade MD, Bacellar MS, Barbosa MR, Clausell NO, Dutra OP, Coelho OR, Yu PC, Lavítola PL, Lemos Neto PA, Andrade PB, Farsky PS, Franco RA, Kalil RA, Lopes RD, Esporcatte R, Heinisch RH, Kalil Filho R, Giraldez RR, Alves RC, Leite RE, Gagliardi RJ, Ramos RF, Montenegro ST, Accorsi TA, Jardim TS, Scudeler TL, Moisés VA, and Portal VL
- Subjects
- Acute Coronary Syndrome drug therapy, Atrial Fibrillation drug therapy, Brazil, Chagas Disease drug therapy, Female, Heart Failure drug therapy, Humans, Ischemic Attack, Transient drug therapy, Myocardial Infarction drug therapy, Perioperative Period, Societies, Medical, Stroke drug therapy, Venous Thromboembolism drug therapy, Anticoagulants therapeutic use, Cardiovascular Diseases drug therapy, Platelet Aggregation Inhibitors therapeutic use
- Published
- 2013
- Full Text
- View/download PDF
18. I Brazilian guidelines on myocarditis and pericarditis.
- Author
-
Montera MW, Mesquita ET, Colafranceschi AS, Oliveira AC Jr, Rabischoffsky A, Ianni BM, Rochitte CE, Mady C, Mesquita CT, Azevedo CF, Bocchi EA, Saad EB, Braga FG, Fernandes F, Ramires FJ, Bacal F, Feitosa GS, Figueira HR, Souza Neto JD, Moura LA, Campos LA, Bittencourt MI, Barbosa Mde M, Moreira Mda C, Higuchi Mde L, Schwartzmann P, Rocha RM, Pereira SB, Mangini S, Martins SM, Bordignon S, and Salles VA
- Subjects
- Brazil, Humans, Myocarditis etiology, Pericarditis etiology, Myocarditis diagnosis, Myocarditis therapy, Pericarditis diagnosis, Pericarditis therapy
- Published
- 2013
- Full Text
- View/download PDF
19. Summary of the II Brazilian Guideline update on Acute Heart Failure 2009/2011.
- Author
-
Montera MW, Pereira SB, Colafranceschi AS, Almeida DR, Tinoco EM, Rocha RM, Moura LA, Réa-Neto Á, Mangini S, Braga FG, Albuquerque DC, Stefanini E, Saad EB, Vilas-Boas F, Silva FB, Ramires FJ, Soriano FG, Westphal G, Aguiar Ribeiro GC, Almeida Júnior GL, Villacorta Júnior H, Souza Neto JD, Costa JL, Neto JM, Baracioli LM, Beck da Silva Neto L, Camanho LE, Bittencourt MI, Garcia MI, Consolação Vieira Moreira Md, Moritz RD, Gusmão R, Martins SM, Bordignon S, and Fiorelli AI
- Subjects
- Acute Disease, Brazil, Heart Failure mortality, Humans, Heart Failure diagnosis, Heart Failure therapy
- Abstract
In the past two years we observed several changes in the diagnostic and therapeutic approach of patients with acute heart failure (acute HF), which led us to the need of performing a summary update of the II Brazilian Guidelines on Acute Heart Failure 2009. In the diagnostic evaluation, the diagnostic flowchart was simplified and the role of clinical assessment and echocardiography was enhanced. In the clinical-hemodynamic evaluation on admission, the hemodynamic echocardiography gained prominence as an aid to define this condition in patients with acute HF in the emergency room. In the prognostic evaluation, the role of biomarkers was better established and the criteria and prognostic value of the cardiorenal syndrome was better defined. The therapeutic approach flowcharts were revised, and are now simpler and more objective. Among the advances in drug therapy, the safety and importance of the maintenance or introduction of beta-blockers in the admission treatment are highlighted. Anticoagulation, according to new evidence, gained a wider range of indications. The presentation hemodynamic models of acute pulmonary edema were well established, with their different therapeutic approaches, as well as new levels of indication and evidence. In the surgical treatment of acute HF, CABG, the approach to mechanical lesions and heart transplantation were reviewed and updated. This update strengthens the II Brazilian Guidelines on Acute Heart Failure to keep it updated and refreshed. All clinical cardiologists who deal with patients with acute HF will find, in the guidelines and its summary, important tools to help them with the clinical practice for better diagnosis and treatment of their patients.
- Published
- 2012
- Full Text
- View/download PDF
20. [Updating of the Brazilian guideline for chronic heart failure - 2012].
- Author
-
Bocchi EA, Marcondes-Braga FG, Bacal F, Ferraz AS, Albuquerque D, Rodrigues Dde A, Mesquita ET, Vilas-Boas F, Cruz F, Ramires F, Villacorta H Jr, Souza Neto JD, Rossi Neto JM, Moura LZ, Beck-da-Silva L, Moreira LF, Rohde LE, Montera MW, Simões MV, Moreira Mda C, Clausell N, Bestetti R, Mourilhe-Rocha R, Mangini S, Rassi S, Ayub-Ferreira SM, Martins SM, Bordignon S, and Issa VS
- Subjects
- Brazil, Controlled Clinical Trials as Topic, Humans, Prognosis, Randomized Controlled Trials as Topic, Heart Failure therapy
- Published
- 2012
- Full Text
- View/download PDF
21. [First guidelines of the Brazilian Society of Cardiology on processes and skills for education in cardiology in Brazil].
- Author
-
Sousa MR, Feitosa GS, Paola AA, Schneider JC, Feitosa-Filho GS, Nicolau JC, Ferreira JF, Carvalho RC, Chalela WA, Malachias MV, Pena JL, Somaio-Neto F, Montera MW, Barbosa GV, Bacal F, Jatene IB, Santos RD, Miranda RD, Peixoto JM, Barbosa MR, Fenelon G, Assef AH, Naccarato AF, Rodrigues Sobrinho CR, Kohler I, Vasconcelos JN, Magalhães MJ, Morais NS, Rocha RM, Giraldez RR, and Silva GC
- Subjects
- Humans, Societies, Medical, Cardiology education, Clinical Competence, Curriculum, Specialization
- Published
- 2011
- Full Text
- View/download PDF
22. [I Brazilian Guideline for Cardio-Oncology from Sociedade Brasileira de Cardiologia].
- Author
-
Kalil Filho R, Hajjar LA, Bacal F, Hoff PM, Diz Mdel P, Galas FR, Fukushima JT, Almeida JP, Nakamura RE, Trielli TR, Bittar CS, Santos MH, Galdeano FG, Auler Júnior JO, Silvestrini AA, Alencar A, Mota AC, Gusmão CA, Almeida DR, Simões CM, Bocchi EA, Lima EM, Fernandes F, Silveira FS, Vilas-Boas F, Beck da Silva Neto L, Rohde LE, Montera MW, Barbosa M, Mano MS, Riechelmann RS, Arai RJ, Martins SM, Ferreira SM, and Santos V
- Subjects
- Cardiovascular Diseases diagnosis, Clinical Trials as Topic, Evidence-Based Medicine, Humans, Antineoplastic Agents adverse effects, Cardiovascular Diseases chemically induced, Heart drug effects, Neoplasms drug therapy
- Published
- 2011
23. [Brazilian Guidelines for Valve Disease - SBC 2011 / I Guideline Inter-American Valve Disease - 2011 SIAC].
- Author
-
Tarasoutchi F, Montera MW, Grinberg M, Piñeiro DJ, Sánchez CR, Bacelar AC, Lopes AS, Fernandes JR, Pires LJ, Moraes RC, Accorsi TA, Colafranceschi AS, Kiyose AT, Fiorelli AI, Bacelar AC, Lopes AS, Ramos AI, Boer BN, Abdulmassih Neto C, Sánchez CR, Esteves CA, Weksler C, Piñeiro DJ, Kruczan DD, Rossi EG, Mesquita ET, de Brito Junior FS, Bacal F, Bosh F, Urzua FF, Moraes F, Tarasoutchi F, Costa FD, Barbosa GV, Spina GS, Murad H, Hernández HM, Fernandes JR, Mangione JA, Brito JC, Murillo JR, Plana JC, Paganini JJ, Krauss J, Moura LA, Pires LJ, Carvalho LA, Cardoso LF, Katz M, Vieira ML, Montera MW, Barbosa Mde M, Barbosa Mde R, Grinberg M, Villagrán OA, Pomerantzeff PM, Lavitola Pde L, Moraes RC, Leite RE, Sampaio RO, Franco S, Martins SM, Bordignon S, Accorsi TA, David TE, Duré VR, Rossei V, and Ávila WS
- Subjects
- Brazil epidemiology, Cardiac Catheterization, Cardiology standards, Echocardiography, Heart Valve Diseases epidemiology, Humans, Latin America epidemiology, Societies, Medical, Heart Valve Diseases diagnosis, Heart Valve Diseases therapy
- Published
- 2011
- Full Text
- View/download PDF
24. [II Brazilian Guidelines for Cardiac Transplantation].
- Author
-
Bacal F, Neto JD, Fiorelli AI, Mejia J, Marcondes-Braga FG, Mangini S, Oliveira Jde L Jr, de Almeida DR, Azeka E, Dinkhuysen JJ, Moreira Mda C, Neto JM, Bestetti RB, Fernandes JR, Cruz Fd, Ferreira LP, da Costa HM, Pereira AA, Panajotopoulos N, Benvenuti LA, Moura LZ, Vasconcelos GG, Branco JN, Gelape CL, Uchoa RB, Ayub-Ferreira SM, Camargo LF, Colafranceschi AS, Bordignon S, Cipullo R, Horowitz ES, Branco KC, Jatene M, Veiga SL, Marcelino CA, Teixeira Filho GF, Vila JH, and Montera MW
- Subjects
- Brazil, Humans, Tissue Donors, Tissue and Organ Procurement, Heart Transplantation standards
- Published
- 2010
25. Correlation of myocardial interstitial collagen in the right ventricular septum with ventricular function of patients with ischemic cardiomyopathy.
- Author
-
Montera MW, Drumond C, Takiya C, Mesquita CT, Dohmann HF, and Mady C
- Subjects
- Epidemiologic Methods, Female, Humans, Male, Middle Aged, Myocardial Ischemia pathology, Stroke Volume physiology, Ventricular Dysfunction, Left physiopathology, Ventricular Dysfunction, Right physiopathology, Ventricular Septum metabolism, Ventricular Septum pathology, Collagen physiology, Myocardial Ischemia physiopathology, Ventricular Function, Left physiology, Ventricular Function, Right physiology, Ventricular Septum physiopathology
- Abstract
Background: Myocardial collagen content influences ventricular relaxation, contraction, and morphology. Its relationship with ventricular function in patients (Pts) with ischemic cardiomyopathy (ICMP) has not yet been fully studied in humans., Objective: To assess the relationship between interstitial collagen content in non-infarcted areas of the right ventricular septum and ventricular function in ICMP., Methods: 31 pts with coronary artery disease were divided into four groups as follows:The control group consisted of 7 pts with normal left (LVEF) and right (RVEF) ventricular ejection fraction (group C); Group 1: 5 patients with RVEF < 40%; Group 2: 9 pts with LVEF < 40%; and Group 3, 10 pts with biventricular dysfunction. RVEF and LVEF were measured by radionuclide angiography. For quantitative analysis of interstitial collagen volume fraction (CVF), endomyocardial biopsy specimens were taken from the right ventricle and stained with picrosirius red., Results: Mean CVF was significantly higher in group 3, compared with the control group and with groups 1 and 2 (30.2 +/- 7.9% vs. 6.8 +/- 3.3% vs. 15.8 +/- 4.1% vs. 17.5+/-7.7%, respectively; p =0.0001). It was also significantly higher in patients belonging to group 2, compared with those in the control group (17.5 +/- 7.7% vs. 6.8 +/- 3.3%, p =0.0001). CVF was inversely correlated with RVEF (r = - 0.50, p = 0.003) and LVEF (r = -0.70, p = 0.0001)., Conclusion: In ICMP, CVF is elevated in non-infarcted areas of the right ventricular septum and inversely correlated with right and left ventricular function.
- Published
- 2009
- Full Text
- View/download PDF
26. [II Brazilian Guidelines on Acute Cardiac Insufficiency].
- Author
-
Montera MW, Almeida DR, Tinoco EM, Rocha RM, Moura LA, Réa-Neto Á, Pereira SB, Mangini S, Braga FG, Albuquerque DC, Stefanini E, Saad EB, Vilas-Boas F, Silva FB, Ramires FJ, Soriano FG, Westphal G, Ribeiro GC, Almeida Júnior GL, Júnior HV, Neto JD, Costa JL, Neto JM, Baracioli LM, Beck da Silva Neto L, Camanho LE, Bittencourt MI, Garcia MI, Moreira Mda C, Moritz RD, Gusmão R, Martins SM, Bordignon S, and Fiorelli AI
- Subjects
- Humans, Acute Coronary Syndrome diagnosis, Acute Coronary Syndrome therapy
- Published
- 2009
27. [III Brazilian Guidelines on Chronic Heart Failure].
- Author
-
Bocchi EA, Braga FG, Ferreira SM, Rohde LE, Oliveira WA, Almeida DR, Moreira Mda C, Bestetti RB, Bordignon S, Azevedo C, Tinoco EM, Rocha RM, Issa VS, Ferraz A, Cruz Fd, Guimarães GV, Montera Vdos S, Albuquerque DC, Bacal F, Souza GE, Rossi Neto JM, Clausell NO, Martins SM, Siciliano A, Souza Neto JD, Moreira LF, Teixeira RA, Moura LZ, Beck-da-Silva L, Rassi S, Azeka E, Horowitz E, Ramires F, Simões MV, Castro RB, Salemi VM, Villacorta Junior H, Vila JH, Simões R, Albanesi F, and Montera MW
- Subjects
- Brazil, Chronic Disease, Heart Failure prevention & control, Humans, Heart Failure diagnosis, Heart Failure therapy
- Published
- 2009
28. Adult extracorporeal life support: a failed or forgotten concept?
- Author
-
Colafranceschi AS, Monteiro AJ, Canale LS, Campos LA, Montera MW, Silva PR, Fernandes MR, Pinto Ade A, Molas SM, and Mesquita ET
- Subjects
- Adult, Brazil epidemiology, Cardiopulmonary Resuscitation methods, Cardiopulmonary Resuscitation standards, Extracorporeal Membrane Oxygenation mortality, Female, Heart Diseases surgery, Hospital Mortality, Humans, Male, Middle Aged, Multiple Organ Failure therapy, Postoperative Complications mortality, Retrospective Studies, Shock, Cardiogenic mortality, Survival Rate, Extracorporeal Membrane Oxygenation standards, Heart Failure therapy, Heart-Assist Devices, Shock, Cardiogenic therapy
- Abstract
Background: The extracorporeal membrane oxygenation (ECMO) has been used in the neonatal and childhood periods with excellent results. The adult experience has been modest with inferior immediate results. The intermediate survival, however, has been promising. We have been using the extracorporeal membrane oxygenation for temporary mechanical circulatory support of adults that present with acute refractory cardiogenic shock in our institution. There is no other published experience of the use of this system in this scenario in Brazil., Objective: To describe our experience with the use of the extracorporeal membrane oxygenation for circulatory support in adults., Methods: Retrospective analysis of the medical files of patients submitted to the implant of extracorporeal membrane oxygenation system for circulatory assistance in acute and refractory cardiogenic shock., Results: Eleven patients (63,5 yo; 45,5% male) were considered for analysis from 2005 to 2007. Median support time was 77 hours (10-240 h) and 5 patients have survived 30 days (45,5%). Two patients were subsequently submitted to prolonged paracorporeal circulatory assistance. Mortality on ECMO (6 patients) was due to multiple organ failure (66,6%) and refractory bleeding (33,4%)., Conclusion: ECMO system is an option to be used in acute refractory cardiogenic shock as a bridge to recovery or selecting patients that might benefit from prolonged paracorporeal assist devices (bridge to bridge).
- Published
- 2008
- Full Text
- View/download PDF
29. Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia.
- Author
-
Beck-da-Silva L, Rohde LE, Pereira-Barretto AC, de Albuquerque D, Bocchi E, Vilas-Boas F, Moura LZ, Montera MW, Rassi S, and Clausell N
- Subjects
- Adult, Anemia, Iron-Deficiency etiology, Double-Blind Method, Ferric Oxide, Saccharated, Glucaric Acid, Humans, Prospective Studies, Research Design, Anemia, Iron-Deficiency drug therapy, Ferric Compounds therapeutic use, Heart Failure complications, Hematinics therapeutic use
- Abstract
Background: Anemia is a common finding in heart failure (HF) patients and has been associated with increased morbidity and mortality. It is generally denominated as anemia of chronic disease (ACD), but the association with true ferropenic anemia is common. Many studies have investigated the effects of treating anemia in HF patients with either erythropoietin alone or combination of erythropoietin and intravenous iron. However, the effect of iron supplementation alone in HF patients with ACD, ferropenic anemia, or both is unknown., Methods and Results: IRON-HF study is a multicenter, investigator initiated, randomized, double-blind, placebo controlled trial that will enroll anemic HF patients with relatively preserved renal function, low transferrin saturation, low iron levels, and low to moderately elevated ferritin levels. Interventions are iron sucrose intravenously 200 mg once per week for 5 weeks, ferrous sulfate 200 mg by mouth 3 times per day for 8 weeks, or placebo. The primary objective is to assess the impact of iron supplementation (intravenously or by mouth) compared with placebo in HF patients with anemia from deficient iron availability. The primary end point is variation of peak oxygen consumption assessed by ergospirometry over 3-month follow-up. Secondary end points include functional class, brain natriuretic peptide levels, quality of life scores, left ventricular ejection fraction, adverse events, HF hospitalization, and death., Conclusions: The results of IRON-HF should help to clarify the potential clinical impact of mild to moderate anemia correction in HF patients.
- Published
- 2007
- Full Text
- View/download PDF
30. [Prognostic value of the Six-Minute Walk Test in heart failure].
- Author
-
Rubim VS, Drumond Neto C, Romeo JL, and Montera MW
- Subjects
- Female, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Ventricular Dysfunction, Left physiopathology, Cardiac Output, Low diagnosis, Exercise Test, Walking physiology
- Abstract
Objective: This study aimed to assess the true usefulness of the Six-Minute Walk Test as a prognostic indicator and its contribution to clinical practice with heart failure patients., Methods: In order to investigate the actual value of the Six-Minute Walk Test as an objective measure of mortality probability in patients with heart failure, the test was applied to 179 stable patients (120 men and 59 women, mean age 58.32 +/- 12.7 years, with NYHA class II and III heart failure and an ejection fraction (LVEF) of 34.91 +/- 12.4%). Patients were instructed to walk for 6 minutes and then, four hours later, underwent a conventional exercise stress test (as per Naughton Protocol). Patients were followed for an average of eighteen months., Results: The average distance walked was 521.11 +/- 76.1 meters. During the follow-up period, 66 patients (36.9%) died. There was a significant correlation between the distance walked during the test and mortality (p < 0.0001). The logistic regression model identified the distance walked during the test as the most important independent predictor of mortality (p = 0.0001). A distance shorter than 520 meters identified the patients with an increased probability of death. There was a significant correlation between the number of metabolic equivalents (METs) measured during the conventional exercise stress testing and mortality rate (p = 0.0001)., Conclusion: The Six-Minute Walk test is a simple, safe and powerful method to assess the prognosis of patients with NYHA class II and III heart failure. It is an objective examination that may replace the conventional ergometric test for the prognostic evaluation of these patients.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.